Pham QT, Taniyama D, Akabane S, Harada K, et al. TDO2 overexpression correlates with poor prognosis, cancer stemness, and resistance to cetuximab in bladder cancer. Cancer Rep (Hoboken) 2021 Jun 7:e1417. doi: 10.1002/cnr2.1417.
PMID: 34101386